HCA vs IMA · P/E 17, rev $75.60B vs rev $9.2M
HCA Holdings Inc (HCA) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. IMA currently screens at market cap $64.7M.
Not investment advice. Open the HCA and IMA stock pages for the full models.
Not investment advice.